Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kymera Therapeutics, Inc.

45.85
-0.5800-1.25%
Post-market: 45.850.00000.00%16:43 EDT
Volume:296.92K
Turnover:13.68M
Market Cap:3.22B
PE:-14.73
High:46.88
Open:46.51
Low:45.52
Close:46.43
Loading ...

BUZZ-Citigroup starts coverage of Kymera with $52 PT

Reuters
·
13 Mar

Citigroup Initiates Coverage on Kymera Therapeutics With Buy Rating, $52 Price Target

MT Newswires Live
·
13 Mar

BUZZ-Citi starts coverage on 'insulated' SMid biotechs amid healthcare policy uncertainty

Reuters
·
13 Mar

Analysts Offer Insights on Healthcare Companies: Myomo (MYO), Kymera Therapeutics (KYMR) and Anika Therapeutics (ANIK)

TIPRANKS
·
07 Mar

Kymera Therapeutics Grants Performance Stock Units to Executives

TIPRANKS
·
04 Mar

Kymera Therapeutics’ Earnings Call Highlights Progress and Challenges

TIPRANKS
·
01 Mar

Kymera's Q4 Loss Wider Than Expected, Pipeline in Focus

Zacks
·
01 Mar

Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (LMAT), Dyne Therapeutics (DYN) and Kymera Therapeutics (KYMR)

TIPRANKS
·
28 Feb

Kymera Therapeutics: Buy Rating Affirmed Amid Promising STAT6 Program Developments and Adjusted Price Target

TIPRANKS
·
28 Feb

We're Not Very Worried About Kymera Therapeutics' (NASDAQ:KYMR) Cash Burn Rate

Simply Wall St.
·
28 Feb

Kymera Therapeutics: Promising Developments and Strategic Positioning Make It a Compelling Buy

TIPRANKS
·
28 Feb

Kymera Therapeutics Inc (KYMR) Q4 2024 Earnings Call Highlights: Strategic Collaborations and ...

GuruFocus.com
·
28 Feb

Kymera Therapeutics Reports 2024 Financial Results and Pipeline Progress

TIPRANKS
·
28 Feb

Kymera Therapeutics (KYMR) Receives a Buy from TD Cowen

TIPRANKS
·
28 Feb

Kymera Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Stock Track | Kymera Therapeutics Plummets 7.27% in Early Trading on Disappointing Q4 Results

Stock Track
·
27 Feb

Kymera Therapeutics Q4 Net Loss Widens, Collaboration Revenue Falls

MT Newswires Live
·
27 Feb

Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Misses Revenue Estimates

Zacks
·
27 Feb

Earnings Flash (KYMR) Kymera Therapeutics Posts Q4 Revenue $7.4M, vs. FactSet Est of $14.4M

MT Newswires Live
·
27 Feb

Kymera Therapeutics reports Q4 EPS (88c), consensus (79c)

TIPRANKS
·
27 Feb